Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-018435
Date:2021-03-04
Issuer: TURNING POINT THERAPEUTICS, INC. (TPTX)
Original Submission Date:

Reporting Person:

REICH SIEGFRIED
C/O TURNING POINT THERAPEUTICS, INC.
10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-03-04 M 35,550 a $51.28 39,395 direct
COMMON STOCK 2021-03-04 S 3,005 d $102.01 36,390 direct
COMMON STOCK 2021-03-04 S 8,820 d $102.87 27,570 direct
COMMON STOCK 2021-03-04 S 6,220 d $103.65 21,350 direct
COMMON STOCK 2021-03-04 S 2,000 d $104.97 19,350 direct
COMMON STOCK 2021-03-04 S 3,103 d $105.71 16,247 direct
COMMON STOCK 2021-03-04 S 6,716 d $107.13 9,531 direct
COMMON STOCK 2021-03-04 S 3,679 d $107.85 5,852 direct
COMMON STOCK 2021-03-04 S 707 d $108.92 5,145 direct
COMMON STOCK 2021-03-04 S 700 d $110.59 4,445 direct
COMMON STOCK 2021-03-04 S 600 d $111.46 3,845 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 51.28 2021-03-04 deemed execution date M 35,550 (d) 2030-03-01 common stock 35,550 $51.28 114,450 direct
Footnotes
IDfootnote
f1 reported transaction occurred pursuant to a rule 10b5-1 plan adopted by the reporting person on november 23, 2020.
f2 the weighted average sale price for the transaction reported was $102.01, and the range of prices were between $101.37 and $102.32. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f3 the weighted average sale price for the transaction reported was $102.87, and the range of prices were between $102.38 and $103.36. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f4 the weighted average sale price for the transaction reported was $103.65, and the range of prices were between $103.40 and $104.20. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f5 the weighted average sale price for the transaction reported was $104.97, and the range of prices were between $104.46 and $105.46. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f6 the weighted average sale price for the transaction reported was $105.71, and the range of prices were between $105.47 and $106.36. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f7 the weighted average sale price for the transaction reported was $107.13, and the range of prices were between $106.53 and $107.53. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f8 the weighted average sale price for the transaction reported was $107.85, and the range of prices were between $107.54 and $108.42. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f9 the weighted average sale price for the transaction reported was $108.92, and the range of prices were between $108.75 and $109.63. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f10 the weighted average sale price for the transaction reported was $110.59, and the range of prices were between $110.05 and $110.96. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f11 the weighted average sale price for the transaction reported was $111.46, and the range of prices were between $111.20 and $111.96. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f12 25% of the shares vested on march 2, 2021 and 1/48th of the shares vest monthly thereafter over the next three years.

Elevate your investments